Cytosorbents
CTSO
#9906
Rank
โ‚ฌ33.33 M
Marketcap
0,53ย โ‚ฌ
Share price
-4.43%
Change (1 day)
-45.61%
Change (1 year)

Market capitalization of Cytosorbents (CTSO)

Market cap: โ‚ฌ33.33 Million

As of February 2026 Cytosorbents has a market cap of โ‚ฌ33.33 Million. This makes Cytosorbents the world's 9906th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Cytosorbents from 2008 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚ฌ33.33 M-8.32%
2025โ‚ฌ36.35 M-26.75%
2024โ‚ฌ49.63 M-5.25%
2023โ‚ฌ52.38 M-16.92%
2022โ‚ฌ63.05 M-60.8%
2021โ‚ฌ0.16 B-42.57%
2020โ‚ฌ0.28 B149.85%
2019โ‚ฌ0.11 B-50.05%
2018โ‚ฌ0.22 B44.39%
2017โ‚ฌ0.15 B17.78%
2016โ‚ฌ0.13 B2%
2015โ‚ฌ0.12 B-32.14%
2014โ‚ฌ0.19 B738.14%
2013โ‚ฌ22.74 M7.67%
2012โ‚ฌ21.12 M-3.34%
2011โ‚ฌ21.85 M69.04%
2010โ‚ฌ12.92 M46.88%
2009โ‚ฌ8.8 M508.87%
2008โ‚ฌ1.44 M

End of Day market cap according to different sources

On Feb 1st, 2026 the market cap of Cytosorbents was reported to be:

โ‚ฌ33.33 Million
by Nasdaq info icon info icon
โ‚ฌ33.33 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Boston Scientific
BSX
โ‚ฌ116.84 B 350,464.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Hologic
HOLX
โ‚ฌ14.09 B 42,177.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Meridian Bioscience
VIVO
โ‚ฌ1.25 B 3,662.84%๐Ÿ‡บ๐Ÿ‡ธ USA